AL-1095

From Wikipedia, the free encyclopedia

Jump to: navigation, search
AL-1095
AL-1095 structure.png
Systematic (IUPAC) name
2-(1-phenyl-1-(p-chlorophenyl)methyl)-3-hydroxyquinuclidine
Legal status
Legal status
  • Unscheduled
Identifiers
CASRN 54549-19-8 N
ATC code none
PubChem CID 3041659
ChemSpider 2304906 YesY
Chemical data
Formula C20H22ClNO
Molar mass 327.139 g/mol
 NYesY (what is this?)  (verify)

AL-1095,[1] developed by Aldrich, is a centrally acting stimulant drug with comparable effects to amphetamine,[2] developed by Bristol in the 1970s.[3]

See also[edit]

References[edit]

  1. ^ US Patent 3506673 -2-(4'HALO)-BENZHYDRYL-3-QUINUCLIDINOLS
  2. ^ Hedblom, P.; Grinspoon, L. (1975). The Speed Culture: Amphetamine Use and Abuse in America. Cambridge: Harvard University Press. p. 50. ISBN 0-674-83192-6. 
  3. ^ Warawa, E. J.; Mueller, N. J.; Gylys, J. A. (1975). "Quinuclidine Chemistry. 3. β-cis-2-(4'-Chlorobenzhydryl)-3-quinuclidinol, a New Central Nervous System Stimulant. Importance of the Benzhydryl Configuration". Journal of Medicinal Chemistry 18 (1): 71–74. doi:10.1021/jm00235a016. PMID 803245.